Mabwell(SH:688062) Shang Hai Zheng Quan Bao·2025-07-06 14:56Core Insights - Private equity firms are increasingly focusing on the technology and pharmaceutical sectors, viewing them as key investment areas [1][3] - In June, private equity managers conducted a total of 1,769 research visits to 387 listed companies, with significant interest in electronic, pharmaceutical, and mechanical equipment sectors [2][3] Group 1: Industry Focus - The technology and pharmaceutical sectors are the most frequently researched areas by private equity firms, with the electronic industry receiving 275 visits and the pharmaceutical industry receiving 266 visits [3] - Notable companies such as Maiwei Biotech received the highest number of visits, totaling 51, indicating strong interest from major private equity firms [2] Group 2: Investment Strategies - Leading private equity firms are not only conducting research but are also actively investing in technology and pharmaceutical sectors, with a focus on new consumption, innovative drugs, and technology stocks [4] - There is a growing optimism regarding the innovative drug sector, with many firms increasing their holdings in this area due to favorable market conditions and the potential for overseas licensing deals [4] Group 3: Market Sentiment - Private equity firms are exhibiting a bullish sentiment towards the Chinese market, with an overall stock position index of 74.62%, indicating a strong investment stance [5] - Among large private equity firms, 52.99% are fully invested (over 80% allocation), reflecting confidence in the market's structural opportunities [5]